Table 2 Sensitivity analysis for different expressions of Ang-2 between NSCLC tissues and normal tissues
From: Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis
Study omitted | Resulting HR (95Â % CI) |
|---|---|
None | 0.87 (0.56–1.18) |
Li 2005 | 0.89 (0.52–1.25) |
Liu 2014 | 0.73 (0.50–0.96) |
Park 2007 | 0.90 (0.47–1.32) |
Park 2009 | 0.98 (0.69–1.27) |
Wan 2008 | 0.85 (0.44–1.26) |